Synbiotics Corporation Appoints Paul R. Hays Chief Executive Officer

Business Wire, March 1, 2005

SAN DIEGO -- Synbiotics Corporation (SBIO) today announced that Paul R. Hays, its President and Chief Operating Officer, has been appointed by the Board of Directors as Chief Executive Officer. Mr. Hays, who has been Synbiotics' President and Chief Operating Officer since December 2002, has executed the responsibilities of Chief Executive Officer since that time as Synbiotics has not officially had a Chief Executive Officer.

"While Mr. Hays' functional responsibilities have not changed," said Thomas A. Donelan, Chairman of Synbiotics' Board of Directors, "the Board of Directors has decided that the strong leadership qualities exhibited by Mr. Hays since joining the company warrant his formal recognition as Chief Executive Officer."

Synbiotics Corporation develops, manufactures and markets veterinary diagnostics, instrumentation and related products for the companion animal, large animal and poultry markets worldwide. Headquartered in San Diego, California, Synbiotics manufactures and distributes its products through its operations in San Diego, CA, and Lyon, France. For information on Synbiotics and its products, visit the Company's website at www.synbiotics.com.

With the exception of historical matters, the issues discussed in this press release are forward-looking statements that are subject to the risks and uncertainties that could cause actual results to differ materially from those anticipated in the forward-looking statements, including competition from larger companies, reliance on third-party manufacturers and distributors, possible technology improvements by others, the seasonality of major portions of the Company's business and other risks set forth in Synbiotics Corporation's filings with the Securities and Exchange Commission, particularly Form 10-K for the year ended December 31, 2003. These forward-looking statements represent Synbiotics Corporation's judgment as of the date of the release. Synbiotics Corporation disclaims, however, any intent or obligation to update these forward-looking statements.